AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Medicare’s New AI-Friendly Payment Model Could Rewire the Health Tech Market
TechCrunch reports that Medicare’s latest payment model may be far more favorable to AI-enabled care than most startups realize. If the policy sticks, it could shift which companies win in digital health by rewarding tools that actually lower costs and improve outcomes rather than simply adding more software.
FDA and CMS Sketch a New Coverage Pathway That Could Shorten the Access Gap for Medical Devices
FDA and CMS have outlined a new pathway intended to speed Medicare coverage decisions for medical devices. If implemented well, it could reduce the long lag between regulatory clearance and real-world patient access. The move signals a broader federal effort to align evidence, reimbursement, and adoption more closely for innovative devices.
FDA and CMS Outline a New Medicare Access Pathway as Device Policy Converges
FDA and CMS have outlined a new Medicare coverage pathway for medical device access, reinforcing the growing convergence between approval and payment policy. The move could make it easier for innovators to turn regulatory success into real patient adoption.
CMMI’s ACCESS Model Shows How Medicare Is Trying to Make AI Work in Payment Reform
Fierce Healthcare’s deeper look at CMMI’s tech-enabled ACCESS Model points to a more consequential use of AI in healthcare: using digital infrastructure to redesign how care is paid for and delivered. The model is less about automation for its own sake than about changing incentives.
FDA Accelerates Medicare Coverage for Breakthrough Medical Devices
The FDA and CMS are moving to speed Medicare coverage for breakthrough devices, reinforcing a broader push to shorten the path from innovation to reimbursement. The move is especially significant for companies that have often seen promising products stall after approval because payment decisions came too late.
CMS and FDA align on a breakthrough device coverage pathway, putting reimbursement on a faster track
CMS and FDA have announced a new pathway intended to accelerate Medicare coverage for breakthrough medical devices. The policy could help promising technologies get to market faster by reducing the uncertainty that often follows regulatory approval. It also underscores how central reimbursement has become to the success of medical innovation.
FDA and CMS outline a new Medicare coverage pathway that could reshape medical device access
A new CMS-FDA pathway is designed to streamline Medicare coverage for breakthrough medical devices. The change could make access faster and more predictable for patients, providers, and investors. The big question is whether speed can be improved without weakening evidence standards.
CMS and FDA launch RAPID pathway to speed Medicare coverage for breakthrough devices
CMS and the FDA have unveiled a new coverage pathway designed to shorten the lag between a breakthrough device’s regulatory approval and Medicare reimbursement. The move could materially improve early patient access, especially for devices aimed at urgent or life-altering conditions. But the policy also raises questions about how much evidence will be enough when coverage decisions are being made faster than ever.
FDA and CMS unveil faster Medicare coverage route for breakthrough medical devices
Federal health officials have introduced a new pathway to speed Medicare coverage for breakthrough devices. The initiative is part reimbursement reform, part innovation policy, and it could reshape how quickly new medtech products reach routine use. The broader significance is that U.S. device access is becoming more explicitly tied to coordinated regulatory and payment decisions.
Medicare Reimbursement Expands, Giving AI a Clearer Path Into Care
AuntMinnie reports that Avenda is highlighting expanded Medicare reimbursement for AI, a development that could accelerate adoption if clinicians can bill for its use. Reimbursement remains one of the biggest determinants of whether healthcare AI becomes a workflow tool or a stranded pilot.
CMS and FDA Unveil a Faster Medicare Path for Breakthrough Devices
Federal regulators are creating a new pathway to accelerate Medicare coverage decisions for breakthrough medical devices, aiming to shorten the gap between FDA authorization and patient access. The move could be a major win for device makers, but it also raises questions about evidentiary standards, payer discretion, and whether speed will outpace real-world validation.
CMS, FDA Launch New Coverage Program for Breakthrough Medical Devices
CMS and the FDA have announced a new program intended to make Medicare coverage decisions for breakthrough devices faster and more coordinated. The initiative could reshape how innovative hardware reaches older adults, but it will test how much uncertainty public payers are willing to absorb.
January AI Lands in the Medicare App Library, Bringing Personalized Health Insights to a Federal Audience
January AI is among the first third-party apps available in the CMS Medicare App Library, a notable milestone for consumer health AI. The move could expand access to personalized insights, while also signaling that federal distribution channels are starting to shape digital health adoption.
CMS Enlists 150 Digital Health Players for Its ACCESS Model, Signaling a Bigger Role for the Sector in Medicare Innovation
CMS is pulling a wide range of digital health companies and providers into its ACCESS Model, a sign that federal payment and care redesign efforts are increasingly leaning on commercial health tech. The move could give the agency a broader test bed for remote monitoring, virtual care, and AI-enabled workflows while also raising questions about interoperability, oversight, and reimbursement. If successful, the model may shape how digital health participates in Medicare at scale.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.